Lumbar Discectomy Control Study, Risk Factors for Reherniation

NCT02477176 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-09-28

No results posted yet for this study

Summary

The purpose of this 12-month, prospective, multicenter study is to investigate the effect of annular defect size and other risk factors on reherniation and associated costs in primary lumbar discectomy patients.

Conditions

  • Lumbar Spine Disc Herniation

Interventions

OTHER

Discectomy

Lumbar discectomy

Sponsors & Collaborators

  • Intrinsic Therapeutics

    lead INDUSTRY

Principal Investigators

  • David H Kim, MD · New England Baptist Hospital

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-17
Primary Completion
2024-03-31
Completion
2025-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02477176 on ClinicalTrials.gov